About Ariceum Therapeutics
Ariceum Therapeutics is a company based in Berlin (Germany) founded in 2021.. Ariceum Therapeutics has raised $51.64 million across 2 funding rounds from investors including EQT, Andera Partners and Earlybird. Ariceum Therapeutics has completed 1 acquisition, including Theragnostics. Ariceum Therapeutics offers products and services including NephroScan. Ariceum Therapeutics operates in a competitive market with competitors including Advanced Accelerator Applications, SOFIE, Mariana Oncology, AdvanCell and Lantheus, among others.
- Headquarter Berlin, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ariceum Therapeutics Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.64 M (USD)
in 2 rounds
-
Latest Funding Round
$24.92 M (USD), Series A
Apr 18, 2023
-
Investors
EQT
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ariceum Therapeutics
Ariceum Therapeutics offers a comprehensive portfolio of products and services, including NephroScan. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Radiopharmaceutical for visualizing and treating cancer through targeted therapy.
Unlock access to complete
Unlock access to complete
Funding Insights of Ariceum Therapeutics
Ariceum Therapeutics has successfully raised a total of $51.64M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $24.92 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $24.9M
-
First Round
First Round
(08 Jun 2022)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series A - Ariceum Therapeutics | Valuation | Andera Partners , Earlybird | |
| Jun, 2022 | Amount | Series A - Ariceum Therapeutics | Valuation | Healthcap |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ariceum Therapeutics
Ariceum Therapeutics has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include EQT, Andera Partners and Earlybird. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Founded Year | Domain | Location | |
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in innovative drug development companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ariceum Therapeutics
Ariceum Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Theragnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gallium-based diagnostic and therapeutic agents are developed and commercialized.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Ariceum Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ariceum Therapeutics Comparisons
Competitors of Ariceum Therapeutics
Ariceum Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Accelerator Applications, SOFIE, Mariana Oncology, AdvanCell and Lantheus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of molecular imaging systems and radio-pharmaceuticals
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals for solid tumors are developed and pioneered.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic imaging agents and targeted therapeutics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ariceum Therapeutics
Frequently Asked Questions about Ariceum Therapeutics
When was Ariceum Therapeutics founded?
Ariceum Therapeutics was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Ariceum Therapeutics located?
Ariceum Therapeutics is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Who is the current CEO of Ariceum Therapeutics?
Manfred Ruediger is the current CEO of Ariceum Therapeutics.
Is Ariceum Therapeutics a funded company?
Ariceum Therapeutics is a funded company, having raised a total of $51.64M across 2 funding rounds to date. The company's 1st funding round was a Series A of $26.72M, raised on Jun 08, 2022.
What does Ariceum Therapeutics do?
Developer of drugs for systemic targeted radiation therapy to treat cancer. The lead radiopharmaceutical product, satoreotide is an antagonist of the somatostatin type 2 (SST2) receptor. It is used for the treatment of neuroendocrine cancers, small cell lung cancer, and neuroblastoma.
Who are the top competitors of Ariceum Therapeutics?
Ariceum Therapeutics's top competitors include Advanced Accelerator Applications, SOFIE and AdvanCell.
What products or services does Ariceum Therapeutics offer?
Ariceum Therapeutics offers NephroScan.
How many acquisitions has Ariceum Therapeutics made?
Ariceum Therapeutics has made 1 acquisition, including Theragnostics.
Who are Ariceum Therapeutics's investors?
Ariceum Therapeutics has 5 investors. Key investors include EQT, Andera Partners, Earlybird, Pureos Bioventures, and Healthcap.